News & Media

Press Releases

Amolyt Pharma Announces Abstracts Accepted for Presentation at ECE and ENDO

May 5, 2023

Download a PDF: EN or FR

Amolyt Pharma Announces Phase 3 Clinical Trial of Eneboparatide for the Treatment of Hypoparathyroidism following Positive End of Phase 2 Meeting with FDA

May 2, 2023

Download a PDF: EN or FR

Amolyt Pharma Announces Research Agreement and Licensing Option with XOMA

January 24, 2023

Download a PDF: EN or FR

Presentations

Eneboparatide (AZP-3601)

KOL Event on Eneboparatide: A PTHR1 Agonist for Hypoparathyroidism

Written by

Dan Hennings

Eneboparatide (AZP-3601)

Eneboparatide Development Update. ENDO 2023 KOL Event Presentation.

Written by

Dan Hennings

Eneboparatide (AZP-3601)

Treatment of Chronic Hypoparathyroidism with Eneboparatide (AZP-3601), a Novel PTH 1 Receptor Agonist: Results from a Phase 2 trial. ENDO 2023 Presentation.

Written by

Dan Hennings

Eneboparatide (AZP-3601)

Eneboparatide, a novel PTH1 receptor agonist, induces rapid reduction and normalization of urinary calcium in hypoparathyroid patients. ENDO 2023 Poster.

Written by

Dan Hennings

Eneboparatide (AZP-3601)

Variations in Clinical Practice Patterns for Hypoparathyroidism. ENDO 2023 Poster.

Written by

Dan Hennings

Upcoming events

26^th European Congress of Endocrinology (ECE)

Date: May 11-14, 2024 (Stockholm, Sweden)

World Hypoparathyroidism Awareness Day

Date: June 1, 2024

2024 Endocrine Society Meeting (ENDO)

Date: June 1-4, 2024 (Boston, MA)

BIO International Convention

Date: June 3-6, 2024 (San Diego, CA)

American Society for Bone and Mineral Research 2024 Annual Meeting (ASBMR)

Date: September 27-30, 2024 (Toronto, Canada)

40^th Congress of the French Society of Endocrinology

Date: October 16-18, 2024 (Clermont-Ferrand, France)

Acromegaly Awareness Day

Date: November 1, 2024

Cookie	Duration	Description
__cf_bm	30 minutes	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management while using Vimeo.
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Analytics" category.
cookielawinfo-checkbox-functional	1 year	Set by the GDPR Cookie Consent plugin, this cookie stores user consent for cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie records the user consent for the cookies in the "Necessary" category.
CookieLawInfoConsent	1 year	CookieYes sets this cookie to record the default button state of the corresponding category and the status of CCPA. It works only in coordination with the primary cookie.
elementor	never	The website's WordPress theme uses this cookie. It allows the website owner to implement or change the website's content in real-time.
viewed_cookie_policy	1 year	The GDPR Cookie Consent plugin sets the cookie to store whether or not the user has consented to use cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	1 year 1 month 4 days	Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors.
_ga_*	1 year 1 month 4 days	Google Analytics sets this cookie to store and count page views.

News & Media

Press Releases

Presentations

Upcoming events

Social Updates

TWITTER